Predictors for low coverage of uptake of second dose of measles vaccine among children in sub-Saharan Africa, 2023: a systematic review and meta-analysis

References

• Abadura, S. A., Lerebo, W. T., Kulkarni, U., & Mekonnen, Z. A. (2015). Individual and community level determinants of childhood full immunization in Ethiopia: A multilevel analysis. BMC Public Health, 15(1), 1–10. https://doi.org/10.1186/s12889-015-2315-z
   PubMedGoogle Scholar
• Akalu, H. B. (2015). Review on measles situation in Ethiopia; past and present. Journal of Tropical Diseases & Public Health, 4, 2. https://doi.org/10.4172/2329-891X.1000193.
   Google Scholar
• Chilot, D., Belay, D. G., Shitu, K., Gela, Y. Y., Getnet, M., Mulat, B., Muluneh, A. G., Merid, M. W., Bitew, D. A., & Alem, A. Z. (2022). Measles second dose vaccine utilization and associated factors among children aged 24–35 months in sub-Saharan Africa, a multi-level analysis from recent DHS surveys. BMC Public Health, 22(1), 1–12. https://doi.org/10.1186/s12889-022-14478-x
   PubMedGoogle Scholar
• Demewoz, A., Wubie, M., Mengie, M. G., Kassegn, E. M., Jara, D., Aschale, A., & Endalew, B. (2023). Second dose measles vaccination utilization and associated factors in Jabitehnan District, Northwest Ethiopia. Dose-Response, 21(1), 15593258231164042. https://doi.org/10.1177/15593258231164042
   Web of Science ®Google Scholar
• Diress, G., Dagne, S., Alemnew, B., Adane, S., & Addisu, A. (2020). Viral load suppression after enhanced adherence counseling and its predictors among high viral load HIV seropositive people in North Wollo Zone public hospitals, Northeast Ethiopia, 2019: Retrospective cohort study. AIDS Research and Treatment, Article ID 8909232, 9. https://doi.org/10.1155/2020/8909232
   Web of Science ®Google Scholar
• Gagneur, A., Pinquier, D., Aubert, M., Balu, L., Brissaud, O., De Pontual, L., Le Guen, C. G., Hau-Rainsard, I., Mory, O., Picherot, G., Stephan, J.-L., Cohen, B., Caulin, E., Soubeyrand, B., & Reinert, P. (2008). Kinetics of decline in maternal measles neutralizing serum antibodies in infants in France in 2006. Clinical and Vaccine Immunology, 15(12), 1845–1850. https://doi.org/10.1128/CVI.00229-08
   PubMedGoogle Scholar
• Garly, M.-L., Martins, C. L., Balé, C., da Costa, F., Dias, F., Whittle, H., & Aaby, P. (1999). Early two-dose measles vaccination schedule in Guinea-Bissau: Good protection and coverage in infancy. International Journal of Epidemiology, 28(2), 347–352. https://doi.org/10.1093/ije/28.2.347
   PubMed Web of Science ®Google Scholar
• Goodson, J. L., Masresha, B. G., Wannemuehler, K., Uzicanin, A., & Cochi, S. (2011). Changing epidemiology of measles in Africa. Journal of Infectious Diseases, 204(Suppl_1), S205–SS14. https://doi.org/10.1093/infdis/jir129
   PubMedGoogle Scholar
• Griffin, D. E., Lin, W.-H., & Pan, C.-H. (2012). Measles virus, immune control, and persistence. FEMS Microbiology Reviews, 36(3), 649–662. https://doi.org/10.1111/j.1574-6976.2012.00330.x
   PubMed Web of Science ®Google Scholar
• Harris, J. B., Marta, G. -D., Eggers, R., Brown, D. W., Sodha, S. V., & Centers for Disease Control and Prevention (CDC). (2014). Global routine vaccination coverage, 2013. Morbidity and Mortality Weekly Report, 63(46), 1055.
   PubMed Web of Science ®Google Scholar
• Immunization MoHEPo. (2019, February 11). Expanded programme on immunization, launched measles vaccine second dose.
   Google Scholar
• Koala, D., Kleme, M.-L., Ouedraogo, I., Savadogo, I., Ouedraogo, W. T., Ahawo, A. K., Tall, H., & Zoungrana, K. A. (2022). Factors associated with the low immunization coverage in the second year of life in the central region of Burkina Faso. Fortune Journal of Health Sciences, 5(4), 596–602. https://doi.org/10.26502/fjhs.089
   Google Scholar
• Landoh, D. E., Ouro-Kavalah, F., Yaya, I., Kahn, A.-L., Wasswa, P., Lacle, A., Nassoury, D. I., Gitta, S. N., & Soura, A. B. (2016). Predictors of incomplete immunization coverage among one to five years old children in Togo. BMC Public Health, 16(1), 1–7. https://doi.org/10.1186/s12889-016-3625-5
   PubMed Web of Science ®Google Scholar
• Laryea, D. O., Abbeyquaye Parbie, E., & Frimpong, E. (2014). Timeliness of childhood vaccine uptake among children attending a tertiary health service facility-based immunization clinic in Ghana. BMC Public Health, 14(1), 1–5. https://doi.org/10.1186/1471-2458-14-90
   PubMedGoogle Scholar
• Magodi, R., Mmbaga, E. J., Massaga, J., Lyimo, D., Mphuru, A., & Abade, A. (2019). Factors associated with non-uptake of measles-rubella vaccine second dose among children under five years in Mtwara district council, Tanzania, 2017. The Pan African Medical Journal, 33. https://doi.org/10.11604/pamj.2019.33.67.17055
   PubMed Web of Science ®Google Scholar
• Makam, L., Mathew, J., Ratho, R., Dutta, S., Singh, M., Bharti, B., Suri, V., & Massey, D. (2019). G147 randomized controlled trial comparing anticipated measles vaccination schedules to routine vaccination starting at 9 months in Indian infants. BMJ Publishing Group Ltd.
   Google Scholar
• Makokha, F., Wanjala, P., Githuku, J., & Kutima, H. (2015). Uptake of a second dose of measles-containing vaccine among children in Kakamega County, Kenya. International Journal of Scientific and Research Publications, 5(7), 1–4.
   Google Scholar
• Mamuti, S., Tabu, C., Marete, I., Opili, D., Jalang’o, R., & Abade, A. (2022). Measles containing vaccine coverage and factors associated with its uptake among children aged 24–59 months in Cherangany Sub County, Trans Nzoia County, Kenya. PLoS One, 17(2), e0263780. https://doi.org/10.1371/journal.pone.0263780
   PubMed Web of Science ®Google Scholar
• Masresha, B. G., Luce, R., Okeibunor, J., Shibeshi, M. E., Kamadjeu, R., & Fall, A. (2018). Introduction of the second dose of measles-containing vaccine in the childhood vaccination programs within the WHO Africa region–lessons learned. Journal of Immunological Sciences, S (017), 113–121.
   Google Scholar
• Muluneh, A. G., Merid, M. W., Tigabu, B., Ferede, M. G., Kassa, G. M., & Animut, Y. (2022). Less than one-fifth of Ethiopian children were vaccinated for measles second dose; evidence from the Ethiopian mini demographic and health survey 2019. Vaccine, X(12), 100217.
   Google Scholar
• Nchimunya, M., Chanda, D., & Musenge, E. (2023). Factors contributing to the acceptability of second dose of measles vaccine among children in Livingstone district, Zambia. Open Journal of Pediatrics, 13(2), 220–234. https://doi.org/10.4236/ojped.2023.132028
   Google Scholar
• Njie-Jobe, J., Nyamweya, S., Miles, D. J., van der Sande, M., Zaman, S., Touray, E., Hossin, S., Adetifa, J., Palmero, M., Burl, S., Jeffries, D., Rowland-Jones, S., Flanagan, K., Jaye, A., & Whittle, H. (2012). Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 years. Vaccine, 30(15), 2543–2550. https://doi.org/10.1016/j.vaccine.2012.01.083
   PubMed Web of Science ®Google Scholar
• Ogutu, J. O., Francis, G. M., Kamau, D. M., Owiny, M. O., Oyugi, E. O., & Ettyang, G. K. (2023). Factors associated with low coverage of the second dose of measles containing vaccine among children aged 19–59 months, Alego-Usonga sub-county, Kenya, 2020. Journal of Interventional Epidemiology and Public Health, 6(1). https://www.afenet-journal.net/content/article/6/1/full
   Google Scholar
• Okwaraji, Y. B., Mulholland, K., Schellenberg, J., Andarge, G., Admassu, M., & Edmond, K. M. (2012). The association between travel time to health facilities and childhood vaccine coverage in rural Ethiopia. A community-based cross-sectional study. BMC Public Health, 12(1), 1–9. https://doi.org/10.1186/1471-2458-12-476
   PubMed Web of Science ®Google Scholar
• Onoja, A., & Ajagbe, O. (2019). Measles in developing countries, 1–10. Retrieved September 26, 2021, from http://www.who.int/immunization/monitoring_surveillance/burden/vpd/WHO_SurveillanceVaccinePreventable_11_Measles_R2.pdf
   Google Scholar
• Patel, M. K., Goodson, J. L., Alexander, J. P., Kretsinger, K., Sodha, S. V., Steulet, C., Gacic-Dobo, M., Rota, P. A., McFarland, J., Menning, L., Mulders, M. N., & Crowcroft, N. S. (2020). Progress toward regional measles elimination—worldwide, 2000–2019. MMWR. Morbidity and Mortality Weekly Report, 69(45), 1700–1705. https://doi.org/10.15585/mmwr.mm6945a6
   PubMed Web of Science ®Google Scholar
• Perry, R. T., Gacic-Dobo, M., Dabbagh, A., Mulders, M. N., Strebel, P. M., Okwo-Bele, J.-M., Rota, P. A., & Goodson, J. L. (2014). Progress toward regional measles elimination—worldwide, 2000–2013. Morbidity and Mortality Weekly Report, 63(45), 1034.
   PubMed Web of Science ®Google Scholar
• PTRoSRaM-A. Retrieved November 18, 2021, from http://www.prismastatement.orgPRISMA/Statement/Checklist.aspx
   Google Scholar
• Russo, G., Miglietta, A., Pezzotti, P., Biguioh, R. M., Bouting Mayaka, G., Sobze, M. S., Stefanelli, P., Vullo, V., & Rezza, G. (2015). Vaccine coverage and determinants of incomplete vaccination in children aged 12–23 months in Dschang, West Region, Cameroon: A cross-sectional survey during a polio outbreak. BMC Public Health, 15(1), 1–11. https://doi.org/10.1186/s12889-015-2000-2
   PubMedGoogle Scholar
• Strebel, P., Cochi, S., Grabowsky, M., Bilous, J., Hersh, B. S., Okwo-Bele, J. M., Hoekstra, E., Wright, P., & Katz, S. (2003). The unfinished measles immunization agenda. The Journal of Infectious Diseases, 187(Supplement_1), S1–S7. https://doi.org/10.1086/368226
   PubMedGoogle Scholar
• Sugishita, Y., Kurita, J., Akagi, T., Sugawara, T., & Ohkusa, Y. (2019). Determinants of vaccination coverage for the second dose of measles-rubella vaccine in Tokyo, Japan. The Tohoku Journal of Experimental Medicine, 249(4), 265–273. https://doi.org/10.1620/tjem.249.265
   PubMed Web of Science ®Google Scholar
• Tadesse, A. W., Sahlu, D., & Benayew, M. (2022). Second-dose measles vaccination and associated factors among under-five children in urban areas of North Shoa Zone, Central Ethiopia, 2022. Frontiers in Public Health, 10, 1029740. https://doi.org/10.3389/fpubh.2022.1029740
   PubMed Web of Science ®Google Scholar
• Tatsuo, H., Ono, N., Tanaka, K., & Yanagi, Y. (2000). SLAM (CDw150) is a cellular receptor for the measles virus. Nature, 406(6798), 893–897. https://doi.org/10.1038/35022579
   PubMed Web of Science ®Google Scholar
• Teshale, A. B., & Amare, T. (2023). Exploring spatial variations and the individual and contextual factors of uptake of measles-containing second dose vaccine among children aged 24 to 35 months in Ethiopia. PLoS One, 18(1), e0280083. https://doi.org/10.1371/journal.pone.0280083
   PubMed Web of Science ®Google Scholar
• UNAIDS JUNPoHA. (2014). 90–90-90: An ambitious treatment target to help end the AIDS epidemic. Accessed 2019, http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf
   Google Scholar
• WHO/Europe. (2015). European vaccine action plan, 98. Retrieved September 26, 2021, from http://www.euro.who.int/__data/assets/pdf_file/0007/255679/WHO_EVAP_ UK_v30_WEBx.pdf
   Google Scholar
• Wiysonge, C. S., Uthman, O. A., Ndumbe, P. M., & Hussey, G. D. (2012). Individual and contextual factors associated with low childhood immunization coverage in sub-Saharan Africa: A multilevel analysis. PLoS One, 7(5), e37905. https://doi.org/10.1371/journal.pone.0037905
   PubMed Web of Science ®Google Scholar
• Wolfson, L. J., Grais, R. F., Luquero, F. J., Birmingham, M. E., & Strebel, P. M. (2009). Estimates of measles case fatality ratios: A comprehensive review of community-based studies. International Journal of Epidemiology, 38(1), 192–205. https://doi.org/10.1093/ije/dyn224
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2002). WHO-UNICEF joint statement on strategies to reduce measles mortality worldwide. Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire, 77(27), 224–228.
   PubMedGoogle Scholar
• World Health Organization. (2009a). Measles vaccine: WHO position paper. Weekly Epidemiological Record, 84, 349–360. https://apps.who.int/iris/bitstream/handle/10665/241403/WER8435_349-360.PDF
   PubMedGoogle Scholar
• World Health Organization. (2009b). WHO position on measles vaccines. Vaccine, 27(52), 7219–7221. https://doi.org/10.1016/j.vaccine.2009.09.116
   PubMedGoogle Scholar
• World Health Organization. (2010). WHO/UNICEF estimates of national immunization coverage. World Health Organization, 2–24.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2012). Global measles and rubella strategic plan: 2012.
   Google Scholar
• World Health Organization. (2017a). Global Health Observatory (GHO) data> measles-containing vaccine first-dose (MCV1) immunization coverage among 1-year-olds.
   Google Scholar
• World Health Organization. (2017b). Measles vaccines. Weekly Epidemiological Record, 92(17), 313–324.
   Google Scholar
• World Health Organization. (2017c). Measles vaccines: WHO position paper, April 2017. Weekly Epidemiological Record, 92, 205–228.
   PubMedGoogle Scholar
• World Health Organization. (2019). Measles vaccines: WHO position paper, April 2017 – recommendations. Vaccine, 37(2), 219–222. https://doi.org/10.1016/j.vaccine.2017.07.066
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2022). Eastern mediterranean, vaccine preventable diseases and immunization, progress towards measles elimination in the region.
   Google Scholar
• Zealiyas, K. (2020). STD & HIV/AIDS 2018: Viral load suppression status and associated factors among patient on antiretroviral treatment in Ethiopia – Kidist Zealiyas – Ethiopian Public Health Institute, Ethiopia. 6(2).
   Google Scholar